Evidence map›Paper›PMID 36105950›Full record

ArticleRSC advances2022

Towards novel tacrine analogues: Pd(dppf)Cl

Aravinda Babu, Muthipeedika Nibin Joy, K Sunil, Ayyiliath Meleveetil Sajith, Sougata Santra, Grigory V Zyryanov, Olga A Konovalova, Ilya I Butorin, Keesaram Muniraju

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Aravinda BabuDepartment of Chemistry, SSIT, Sri Siddhartha Academy of Higher Education Tumkur Karnataka India-572107 sunilk999@gmail.com sajithmeleveetil@gmail.com +91-9480146151.
Muthipeedika Nibin JoyInstitute of Chemical Technology, Ural Federal University 19 Mira Street Yekaterinburg Russia-620002.
K SunilDepartment of Chemistry, SSIT, Sri Siddhartha Academy of Higher Education Tumkur Karnataka India-572107 sunilk999@gmail.com sajithmeleveetil@gmail.com +91-9480146151.ORCID https://orcid.org/0000-0002-1283-4278
Ayyiliath Meleveetil SajithDepartment of Chemistry, SSIT, Sri Siddhartha Academy of Higher Education Tumkur Karnataka India-572107 sunilk999@gmail.com sajithmeleveetil@gmail.com +91-9480146151.
Sougata SantraInstitute of Chemical Technology, Ural Federal University 19 Mira Street Yekaterinburg Russia-620002.ORCID https://orcid.org/0000-0002-4186-6105
Grigory V ZyryanovInstitute of Chemical Technology, Ural Federal University 19 Mira Street Yekaterinburg Russia-620002.
Olga A KonovalovaInstitute of Chemical Technology, Ural Federal University 19 Mira Street Yekaterinburg Russia-620002.
Ilya I ButorinInstitute of Chemical Technology, Ural Federal University 19 Mira Street Yekaterinburg Russia-620002.
Keesaram MunirajuGovernment Degree College-Puttur (Affiliated to S. V. University, Tirupati) Narayanavanam Road, Puttur, Chittoor (Dt) Andhra Pradesh India-517583.
Ural Federal University · RUSri Siddhartha Academy of Higher EducationSri Venkateswara University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A plethora of 6-(hetero)aryl C-C and C-N bonded tacrine analogues has been made accessible by employing palladium mediated (Suzuki-Miyaura, Heck, Sonogashira, Stille and Buchwald) cross-coupling reactions, starting from either halogenated or borylated residues. The successful use of Pd(dppf)Cl

Identifiers

PMID36105950
PMCPMC9366599
OpenAlexW4291015271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.